About Us

About Us

Providing Our Clients with The Best Products

6

Company Information

HymonBio Co., Ltd. was established in 2015, with co-founder from the Chinese Academy of Sciences. The company focuses on the development, production, and sale of precision-medicine and point-of-care (POCT) related products. Since its establishment in Taicang BIOBAY, HymonBio has applied for 42 patents and obtained 18 authorized patents; 11 products have obtained Chinese medical device certificates; 59 products have obtained CE certificates; 1 product has obtained an FDA certificate and passed the ISO13485 system certificate. 

The company has won awards such as high-tech enterprises, private technology enterprises in Jiangsu Province, enterprises supported by the "Double Innovation Plan" of Jiangsu Province, and Suzhou Female Innovation and Entrepreneurship Leading Talent Enterprises. Most recently, HymonBio has completed the first round of financing, which is also the first overseas investment project of PerkinElmer Ventures, a leading company in the IVD industry, in China.

Our Focus

Relate to Precision Medicine and Point-of-Care Testing(POCT)

Our Model

Promote the Project into the Market through Cooperation, Rather than Maximizing the Benefits of a Single Product

Our Slogan

Use Limited Resources and Cooperation to Speed up the Promotion of New Products. 

Team Leaders

1-tammy

Tan Miao / Founder and CEO

> CEO of HymonBio. She received her doctorate from the Chinese Academy of Sciences in 2006 and was a visiting scholar of Max Planck Institute in Germany from 2005 to 2006.

> She previously served as the R&D project manager of IVD-listed companies and was responsible for team management. Person in charge of national major special projects of the Ministry of science and technology. Member of the national health industry medical laboratory Expert Committee. Four SCI papers were published in international journals. 3 patented technologies. 2016 doctor of entrepreneurship and innovation in Jiangsu Province and Suzhou talents in 2017.

1 (2)

Ma Xiaojuan/GM

> Project Director of HymonBio. She received her Master's degree from Yangzhou University in 2005. One of the co-founders of HymonBio, she focuses on the development and promotion of molecular diagnostics products.

> She has more than 10 years of experience in the IVD industry; had been the R&D manager of listed companies; has served as foreign enterprises quality control manager; and assistant director of sales and marketing.